We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
AMSBIO Expands US Operations
News

AMSBIO Expands US Operations

AMSBIO Expands US Operations
News

AMSBIO Expands US Operations

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "AMSBIO Expands US Operations"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AMSBIO has announced the opening of a new North American headquarters with executive management facilities in Cambridge, MA for its US subsidiary - AMSBIO LLC.

Commenting on this strategic move, Alex Sim (President, AMSBIO) said “The US is the single largest market for our stem cell and regenerative medicine, glycobiology enzymes / substrates and tissue derived products. Drawing upon our in-depth expertise in extracellular matrices we are able to also provide elegant solutions for studying cell motility, migration, invasion and proliferation”.

He added “Our North American customer base has been growing strongly over recent years. From the new East Coast facility we will provide local informed service and support as well as next day delivery of a comprehensive range of enabling technology products to help improve the productivity of our US customers”.

Advertisement